Hypera SA (HYPE3)

Currency in BRL
23.18
+0.40(+1.76%)
Closed·
High dividend Yield
HYPE3 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.5723.37
52 wk Range
17.1628.56
Key Statistics
Bid/Ask
23.18 / 23.21
Prev. Close
22.78
Open
22.73
Day's Range
22.57-23.37
52 wk Range
17.16-28.56
Volume
2.56M
Average Volume (3m)
2.64M
1-Year Change
29.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HYPE3 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.24
Upside
+30.47%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Hypera SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Hypera Company Profile

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.

Employees
10481
Market
Brazil

Compare HYPE3 to Peers and Sector

Metrics to compare
HYPE3
Peers
Sector
Relationship
P/E Ratio
17.5x12.1x−0.6x
PEG Ratio
−0.370.030.00
Price/Book
1.2x1.4x2.6x
Price / LTM Sales
2.1x1.7x3.2x
Upside (Analyst Target)
31.7%29.4%41.8%
Fair Value Upside
Unlock6.2%5.1%Unlock

Analyst Ratings

8 Buy
6 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30.24
(+30.47% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Scotiabank
Buy35.00+50.99%-New Coverage17/07/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.29%
Dividend Yield
5.05%
Industry Median 2.39%
Annualised payout
1.17
Paid unevenly
5-Years Growth
+34.91%
Growth Streak

Earnings

Latest Release
Oct 28, 2025
EPS / Forecast
0.72 / 0.6947
Revenue / Forecast
2.23B / 2.26B
EPS Revisions
Last 90 days

Hypera (HYPE3) Income Statement & Profits

People Also Watch

38.43
EQTL3
+2.21%
21.48
TIMS3
+0.37%
51.49
CPFE3
+2.59%
6.51
POMO4
+1.09%
15.76
BRAV3
+0.38%

FAQ

What Is the Hypera (HYPE3) Share Price Today?

The live Hypera share price today is 23.18

What Stock Exchange Does Hypera (HYPE3) Trade On?

Hypera is listed and trades on the B3 Stock Exchange.

What Is the Ticker (Stock Symbol) for Hypera?

The stock symbol (also called a 'ticker') for Hypera is "HYPE3."

Does Hypera Pay Dividends? What’s The Current HYPE3 Dividend Yield?

Yes, HYPE3 Pays Dividends to its Shareholders. The current Hypera dividend yield is 5.05%.

What Is the Current Hypera Market Cap?

As of today, Hypera market capitalisation is 14.64B.

What Is Hypera's (HYPE3) Earnings Per Share (TTM)?

The Hypera EPS is currently 1.29 (Trailing Twelve Months).

When Is the Next Hypera Earnings Date?

Hypera's next earnings report will be released on 20 Feb 2026.

Is HYPE3 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Hypera moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Hypera Stock Split?

Hypera has split 2 times. (See the HYPE3 stock split history page for full effective split date and price information.)

How Many Employees Does Hypera Have?

Hypera has 10481 employees.

What is the current trading status of Hypera (HYPE3)?

As of 24 Dec 2025, Hypera (HYPE3) is trading at a price of 23.18, with a previous close of 22.78. The stock has fluctuated within a day range of 22.57 to 23.37, while its 52-week range spans from 17.16 to 28.56.

What Is Hypera (HYPE3) Price Target According to Analysts?

The average 12-month price target for Hypera is BRL30.24286, with a high estimate of BRL35 and a low estimate of BRL25. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +30.47% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.